Tim Eisen
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Renal cell carcinoma treatment 78
- Lung Cancer Treatments and Mutations 9
-
- Renal and related cancers 28
- Melanoma and MAPK Pathways 13
- Co-authors
- Martin Gore (26 shared papers)Walter M. Stadler (11 shared papers)Bernard Escudier (18 shared papers)Brian Schwartz (6 shared papers)Ronald M. Bukowski (8 shared papers)Cezary Szczylik (10 shared papers)Apurva A. Desai (3 shared papers)Minghua Shan (3 shared papers)
- Journals
- Journal of Clinical Oncology (29 papers)British Journal of Cancer (13 papers)Clinical Cancer Research (5 papers)British Journal of Urology (5 papers)Lung Cancer (5 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Tim Eisen
145 papers receiving 13.0k citations
Tim Eisen's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 3.1k
- Pulmonary and Respiratory Medicine 6.3k
- Oncology 3.3k
- Molecular Biology 5.8k
- Hepatology 304
Countries citing papers authored by Tim Eisen
This map shows the geographic impact of Tim Eisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Eisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Eisen more than expected).
Fields of papers citing papers by Tim Eisen
This network shows the impact of papers produced by Tim Eisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Eisen. The network helps show where Tim Eisen may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Eisen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 3955 |
| 2 | Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Hit paper breakdown → | 2009 | 910 |
| 3 | Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2006 | 834 |
| 4 | VHL, the story of a tumour suppressor gene Hit paper breakdown → | 2014 | 575 |
| 5 | Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis Hit paper breakdown → | 2006 | 520 |
| 6 | 2004 | 366 | |
| 7 | Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial Hit paper breakdown → | 2016 | 323 |
| 8 | Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study Hit paper breakdown → | 2014 | 305 |
| 9 | 2000 | 291 | |
| 10 | 2005 | 284 | |
| 11 | 2004 | 219 | |
| 12 | 2005 | 211 | |
| 13 | 2007 | 205 | |
| 14 | 2011 | 151 | |
| 15 | 2010 | 146 | |
| 16 | 2000 | 137 | |
| 17 | 2004 | 122 | |
| 18 | 2011 | 112 | |
| 19 | 2010 | 112 | |
| 20 | 2013 | 111 |
About Tim Eisen
Tim Eisen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 148 papers that have together received 13.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (78 papers), Cancer Genomics and Diagnostics (35 papers), Renal and related cancers (28 papers), Melanoma and MAPK Pathways (13 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cutaneous Melanoma Detection and Management (7 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Cancer Research (3.1k citations), Pulmonary and Respiratory Medicine (6.3k citations), Oncology (3.3k citations), Molecular Biology (5.8k citations) and Hepatology (304 citations). Tim Eisen has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Martin Gore, Walter M. Stadler, Bernard Escudier, Brian Schwartz, Ronald M. Bukowski, Cezary Szczylik, Apurva A. Desai, Minghua Shan, Ronit Simantov and Sylvie Négrier. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Cancer Research, British Journal of Urology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.